UNSPSC 51473309: Resorcinol monoacetate

This classification denotes an anti-infective agent with the molecular formula C8H8O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YL6O37RD1S, chemically known as 1,3-benzenediol, monoacetate but more generally known as resorcinol acetate, which bears US NIH Compound Identifier 5055. European Medicines Agency schedules Resorcinol monoacetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15121MIG. Most nations, for tariff and trade purposes, schedule resorcinol monoacetate under HS 29072100.

As of Q4 2014, RESORCINOL MONOACETATE remains US FDA's Preferred Term for this commodity. Resorcinol monoacetate bears US NLM identifiers UMLS ID C0636149 and NCI Concept Code C84136. SMILES: CC(=O)OC1CCCC(C1)O.

UNSPSC 51473309 Resorcinol monoacetate is a Commodity code that in recent state and local solicitations appears tagged to consumable janitorial supplies and pharmaceutical products rather than to the chemical compound itself. The Hillsborough County Board of County Commissioners' July 2026 ITB for janitorial and operational supplies to support 47 fire stations across Tampa, Florida, and the Minnesota Multistate Cooperative Purchasing Alliance's (MMCAP) January 2026 RFP for generic multi-source pharmaceuticals and over-the-counter products both carry this code, though neither opportunity's scope document explicitly references resorcinol monoacetate as a line item or required component. The code shows minimal distinct recent activity aligned to its nominal chemical definition; state and local governments using this code appear to be aggregating broader consumable procurement under a misaligned or overly broad UNSPSC designation rather than sourcing the specific chemical product the code denotes.

Geographic activity centers on Florida and Minnesota in the recent record. The Hillsborough County ITB (due July 24, 2026) targets $765,679.84 in annual janitorial supplies for fire rescue operations, with delivery to Tampa; the MMCAP RFP (due March 26, 2026) extends multi-state pharmaceutical contracting across Minnesota and Oregon through authorized wholesalers including Cencora, Cardinal Health, and Morris & Dickson. No other state or local opportunities under this code appear in the recent block. Business development professionals should verify whether this code actually governs resorcinol monoacetate procurement in target jurisdictions, or whether the tag reflects a data-entry error or overly inclusive procurement category that obscures the actual commodity being bought.